Cibc Private Wealth Group, LLC Ionis Pharmaceuticals Inc Transaction History
Cibc Private Wealth Group, LLC
- $51.4 Billion
- Q2 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 2,125 shares of IONS stock, worth $89,611. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,125
Previous 2,168
1.98%
Holding current value
$89,611
Previous $93,000
8.6%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding IONS
# of Institutions
394Shares Held
125MCall Options Held
2.25MPut Options Held
510K-
Vanguard Group Inc Valley Forge, PA13.8MShares$584 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD12.6MShares$533 Million0.38% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$435 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.26MShares$348 Million6.59% of portfolio
-
Wellington Management Group LLP Boston, MA6.57MShares$277 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.99B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...